3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
109
Radiotherapy
106
Fluorouracil
76
Doxorubicin
74
Carboplatin
71
Etoposide
67
Cisplatin
67
Vincristine
66
Paclitaxel
58
Chemotherapy, Adjuvant
53
Leucovorin
47
Specimen Handling
43
Cytarabine
42
Magnetic Resonance Spectroscopy
38
Methotrexate
37
Dexamethasone
33
Taxes
31
Bevacizumab
31
Peripheral Blood Stem Cell Transplantation
30
Gemcitabine
30
Filgrastim
30
Docetaxel
30
Tamoxifen
28
Melphalan
28
Immunoglobulin G
25
Epirubicin
25
Disulfides
25
Oxaliplatin
24
Daunorubicin
24
Prednisone
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
NIH
×
Tomography, Spiral Computed
×
Clear all
NCT00047385
2014-05-20
NLST
National Cancer Institute (NCI)
Phase 3
Completed
53,454 enrolled
15 charts